Sepsis: rethinking the approach to clinical research (Q22255578)

Journal of Leukocyte Biology

Europe PubMed Central

title

Sepsis: rethinking the approach to clinical research (English)

0 references

0 references

0 references

J. C. Marshall

1

John C

Marshall

1 reference

8 February 2023

language of work or name

English

0 references

publication date

8 November 2007

0 references

published in

0 references

volume

83

0 references

issue

3

0 references

page(s)

471-482

0 references

cites work

Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Long-term survival and function after suspected gram-negative sepsis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Endotoxemia after major vascular operations

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Signaling pathways activated by microorganisms

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Acute lung injury and the acute respiratory distress syndrome: a clinical review

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Macrophage migration inhibitory factor (mif) transcription is significantly elevated in Caenorhabditis elegans dauer larvae.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

A network-based analysis of systemic inflammation in humans

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The innate signaling of dangers and the dangers of innate signaling

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Such stuff as dreams are made on: mediator-directed therapy in sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Genetic and environmental influences on premature death in adult adoptees

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Drotrecogin Alfa (Activated) in Severe Sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The fecal flora of various strains of mice. Its bearing on their susceptibility to endotoxin

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Increased gene expression of a cytokine-related molecule and profilin after activation of Suberites domuncula cells with xenogeneic sponge molecule(s).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Empiric antimicrobial therapy in critical illness: results of a surgical infection society survey

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

The ancient riddle of sigma eta psi iota sigma (sepsis).

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

New strategies for clinical trials in patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Neutralization of tumor necrosis factor in preclinical models of sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis.

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Influence of Comorbid Conditions on Long-Term Mortality After Pneumonia in Older People

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Physiological functions of caspases beyond cell death

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021

Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0607380

7 January 2021